Vaccinogen Inc.
Records under this name other than the patents Vaccinogen Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,628,996 | Sterile Immunogenic Non-Tumorigenic Tumor Cell Compositions and Methods Lapsed on the fee record Ended Dec 8, 2017 · High confidence | Lapsed on the fee record | Ended Dec 8, 2017 | High confidence |
| US 4,828,991 | Tumor specific monoclonal antibodies Term ended Term ended no later than May 9, 2009 · Low confidence | Term ended | Term ended no later than May 9, 2009 | Low confidence |
| US 5,106,738 | Tumor specific monoclonal antibodies Term ended Term ended no later than Apr 21, 2012 · Low confidence | Term ended | Term ended no later than Apr 21, 2012 | Low confidence |
| US 5,180,814 | Tumor specific monoclonal antibodies Term ended Term ended no later than Jan 19, 2013 · Low confidence | Term ended | Term ended no later than Jan 19, 2013 | Low confidence |
| US 5,292,868 | Chelating agents for attaching metal ions to proteins Term ended Term ended no later than Mar 8, 2014 · Low confidence | Term ended | Term ended no later than Mar 8, 2014 | Low confidence |
| US 5,338,832 | Antigen recognized by MCA 16-88 Term ended Term ended no later than Aug 16, 2014 · Low confidence | Term ended | Term ended no later than Aug 16, 2014 | Low confidence |
| US 5,348,880 | Tumor associated monoclonal antibody 81AV/78 Term ended Term ended no later than Sep 20, 2014 · Low confidence | Term ended | Term ended no later than Sep 20, 2014 | Low confidence |
| US 5,433,955 | Site specific in vivo activation of therapeutic drugs Term ended Term ended no later than Jul 18, 2015 · Low confidence | Term ended | Term ended no later than Jul 18, 2015 | Low confidence |
| US 5,474,755 | Tumor associated monoclonal antibodies Term ended Term ended no later than Dec 12, 2015 · Low confidence | Term ended | Term ended no later than Dec 12, 2015 | Low confidence |
| US 5,484,596 | Active specific immunotherapy Term ended Term ended no later than Jan 16, 2016 · Low confidence | Term ended | Term ended no later than Jan 16, 2016 | Low confidence |